-
Loading metrics
Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer
- Jan Pander,
- Lieke van Huis-Tanja,
- Stefan Böhringer,
- Tahar van der Straaten,
- Hans Gelderblom,
- Cornelis Punt,
- Henk-Jan Guchelaar
x
- Published: July 29, 2015
- https://doi.org/10.1371/journal.pone.0131091